Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) Price Target at $29.70

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) has been given an average rating of “Buy” by the ten ratings firms that are covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $29.70.

ASPN has been the subject of a number of research analyst reports. TD Cowen upped their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Piper Sandler upped their price objective on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, May 29th. Roth Mkm reaffirmed a “buy” rating and set a $36.00 target price on shares of Aspen Aerogels in a report on Wednesday, August 21st. Benchmark reiterated a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, B. Riley upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th.

Check Out Our Latest Stock Report on Aspen Aerogels

Insiders Place Their Bets

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

A number of hedge funds have recently modified their holdings of the business. Point72 Hong Kong Ltd purchased a new position in shares of Aspen Aerogels during the second quarter valued at $84,000. nVerses Capital LLC purchased a new position in Aspen Aerogels during the 2nd quarter valued at about $95,000. Banque Cantonale Vaudoise increased its holdings in shares of Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares during the period. Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels in the second quarter worth approximately $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in shares of Aspen Aerogels during the second quarter worth approximately $145,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Trading Up 15.6 %

NYSE:ASPN opened at $28.76 on Tuesday. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of -65.36 and a beta of 2.16. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. Aspen Aerogels has a 1 year low of $6.26 and a 1 year high of $33.15. The business has a fifty day moving average of $24.90 and a 200-day moving average of $23.13.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. During the same quarter in the prior year, the firm posted ($0.22) EPS. Aspen Aerogels’s revenue was up 144.4% compared to the same quarter last year. Equities analysts predict that Aspen Aerogels will post 0.21 earnings per share for the current year.

Aspen Aerogels Company Profile

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.